Cargando…
Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer’s disease
Abnormal elevation of amyloid β-peptide (Aβ) levels in the brain is the primary trigger for neuronal cell death specific to Alzheimer’s disease (AD). It is now evident that Aβ levels in the brain are manipulable due to a dynamic equilibrium between its production from the amyloid precursor protein (...
Autores principales: | Nalivaeva, Natalia N., Belyaev, Nikolai D., Kerridge, Caroline, Turner, Anthony J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166351/ https://www.ncbi.nlm.nih.gov/pubmed/25278875 http://dx.doi.org/10.3389/fnagi.2014.00235 |
Ejemplares similares
-
The Alzheimer's Amyloid-Degrading Peptidase, Neprilysin: Can We Control It?
por: Nalivaeva, N. N., et al.
Publicado: (2012) -
Role of amyloid precursor protein (APP) in regulation of neuronal genes
por: Nalivaeva, Natalia N.
Publicado: (2015) -
Hypoxia Affects Neprilysin Expression Through Caspase Activation and an APP Intracellular Domain-dependent Mechanism
por: Kerridge, Caroline, et al.
Publicado: (2015) -
Lipid Rafts and Alzheimer’s Disease: Protein-Lipid Interactions and Perturbation of Signaling
por: Hicks, David A., et al.
Publicado: (2012) -
Role of Prenatal Hypoxia in Brain Development, Cognitive Functions, and Neurodegeneration
por: Nalivaeva, Natalia N., et al.
Publicado: (2018)